In glioblastoma, CUDC-907 induces G1 cell cycle arrest through CDKN1A promoter hyperacetylation-driven transcriptional activation and downregulation of CDK1 [36], while in lung fibroblast cells, CUDC-907 blocks G1 and S phase [37]. Here, CDK1 is linked to glioblastoma.